Concepedia
10
Publications
457
Citations
H-Index
1991
Active since
Affiliations
Adamas Pharmaceuticals (United States)(Current)
University of Kansas Medical Center
University of South Florida
University of California, San Francisco
Parkinson's Research and Education Foundation
Reed Johnson is an author at Adamas Pharmaceuticals (United States).
Publications per year
1991–2021
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study)
Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser et al. · JAMA Neurology · 2017 · 170 citations · Full text
Pooled Analyses of Phase III Studies of ADS-5102 (Amantadine) Extended-Release Capsules for Dyskinesia in Parkinson’s Disease
Lawrence Elmer, Jorge L. Juncos, Carlos Singer et al. · CNS Drugs · 2018 · 60 citations · Full text
ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study
Robert A. Hauser, Rajesh Pahwa, Caroline M. Tanner et al. · Journal of Parkinson s Disease · 2017 · 52 citations · Full text
Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia
Robert A. Hauser, Rajesh Pahwa, William A. Wargin et al. · Clinical Pharmacokinetics · 2018 · 44 citations · Full text
EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease
Caroline M. Tanner, Rajesh Pahwa, Robert A. Hauser et al. · Journal of Parkinson s Disease · 2020 · 35 citations · Full text
Rows per page
1–5 of 10